Search

Your search keyword '"Wesson JA"' showing total 738 results

Search Constraints

Start Over You searched for: "Wesson JA" Remove constraint "Wesson JA"
738 results on '"Wesson JA"'

Search Results

1. Comparison of cat stone matrix and cat urine proteomes to human calcium oxalate stone matrix and urine proteomes.

2. Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes.

3. Protein primary structure correlates with calcium oxalate stone matrix preference.

4. Exploring mechanisms of protein influence on calcium oxalate kidney stone formation.

5. Inhibition of NLRP3 alleviates calcium oxalate crystal-induced renal fibrosis and crystal adhesion.

6. Advances in the mechanism of urinary proteins in calcium oxalate kidney stone formation.

7. Integrated proteomics reveals enrichment of oxidative stress and inflammatory proteins in the urine and stone matrix of calcium oxalate stone formers.

8. Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis?

9. Stone former urine proteome demonstrates a cationic shift in protein distribution compared to normal.

10. Guaifenesin stone matrix proteomics: a protocol for identifying proteins critical to stone formation.

11. The role of macromolecules in the formation of kidney stones.

13. Polyisobutylene Urolithiasis Due to Ileal Conduit Urostomy Appliance: An Index Case.

14. Exploring calcium oxalate crystallization: a constant composition approach.

15. Arachidonic acid is involved in high-salt diet-induced coronary remodeling through stimulation of the IRE1α/XBP1s/RUNX2/OPN signaling cascade.

17. Relative deficiency of acidic isoforms of osteopontin from stone former urine.

18. Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein.

19. Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design.

20. Attachment of calcium oxalate monohydrate crystals on patterned surfaces of proteins and lipid bilayers.

21. Induction of apoptosis with cisplatin enhances calcium oxalate crystal adherence to inner medullary collecting duct cells.

22. Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

24. Cefazolin shifts the kidney microbiota to promote a lithogenic environment.

25. Impact of diet on renal stone formation.

26. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.

27. Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers.

28. Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.

29. Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy.

30. An acidic peptide sequence of nucleolin-related protein can mediate the attachment of calcium oxalate to renal tubule cells.

31. Osteopontin and calcium stone formation.

32. Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation.

33. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

34. Osteopontin--a molecule for all seasons.

35. Effects of urinary macromolecules on hydroxyapatite crystal formation.

36. Role of anionic proteins in kidney stone formation: interaction between model anionic polypeptides and calcium oxalate crystals.

37. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules.

39. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.

42. ADIPOKINES AND THEIR ROLE IN ACUTE PANCREATITIS.

43. Evaluation of Antiurolithiatic Potential of Methanolic Stem Extract of Spermacocce articularis L.f.: An In vitro and In vivo Approach.

44. Anti-urolithiatic effect of Cucumis melo L. var inodorous in male rats with kidney stones.

45. An insight investigation to the antiurolithic activity of Trachyspermum ammi using the in vitro and in vivo experiments.

46. Osteopontin phosphopeptide mitigates calcium oxalate stone formation in a Drosophila melanogaster model.

47. Runaway electron mitigation by 3D fields application in ASDEX Upgrade, COMPASS, and RFX-mod.

48. Management of urinary stones: state of the art and future perspectives by experts in stone disease.

49. Case report: Findings in ovaries development from an aborted equine fetus.

50. Dental pulp stones and their correlation with metabolic diseases.

Catalog

Books, media, physical & digital resources